Neuropharmacology and pain

Francisco Ciruela Alferez / Ester Aso Pérez

PRINCIPAL INVESTIGATORS
  • Jordi Bonaventura Morera
  • Víctor Fernández Dueñas
  • África Flores de los Heros
CLINICAL RESEARCHERS
  • Sebastián Videla Cés
  • Pilar Hereu Boher
  • Roser Llop Rius
  • Dolores Rodríguez Cumplido
POSTDOCTORAL RESEARCHERS
  • Alex Fernandez Solanas
  • Marc Lopez Cano
  • Alejandro Martín Belmonte
  • Glòria Salort Flaquer
PREDOCTORAL RESEARCHERS
  • Paula Alvarez Montoya
  • Josep Argerich Bergadà
  • Thiago Carnaval
  • Laura Gómez Acero
  • Arianna Rizzo
  • Nuria Sanchez Fernandez
SCIENTIFIC SUPPORT
  • Aurema Otero González
  • Maria Salut Sanchez Rodriguez
VISITING RESEARCHERS
  • Kristoffer Sahlholm
  • Jiu Lin
Neuroscience
Neuroscience

Scientific production

39

PAPERS

Average IF: 5,580

10

LED PAPERS

Average IF: 5,764

16 PUBLICATIONS IN FIRST DECILE

23 PUBLICATIONS IN FIRST QUARTILE

32 PUBLICATIONS IN OPEN ACCESS

Selected publications:

  • Alemany A, Millat Martinez P, Corbacho Monné M, Malchair P, Ouchi D, Ruiz Comellas A, Ramírez Morros A, Rodríguez Codina J, Amado Simon R, Videla S, Costes G, Capdevila Jáuregui M, Torrano Soler P, San José A, Bonet Papell G, Puig J, Otero A, Ruibal Suarez JC, Zarauza Pellejero A, Llopis Roca F, Rodriguez Cortez O, Garcia V, Vidal Alaball J, Millan A, Contreras E, Grifols JR, Ancochea À, Galvan Femenia I, Piccolo Ferreira F, Bonet M, Cantoni J, Prat N, Ara J, Forcada Arcarons A, Farré M, Pradenas E, Blanco J, Àngel Rodriguez Arias M, Fernández Rivas G, Marks M, Bassat Q, Blanco I, Baro B, Clotet B, Mitjà O, CONV ERT G. High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial. Lancet Respir Med. 2022;10(3):278-288. doi:10.1016/S2213-2600(21)00545-2.
  • Millat Martinez P, Gharbharan A, Alemany A, Rokx C, Geurtsvankessel C, Papageourgiou G, van Geloven N, Jordans C, Groeneveld G, Swaneveld F, van der Schoot E, Corbacho Monné M, Ouchi D, Piccolo Ferreira F, Malchair P, Videla S, García V, Ruiz Comellas A, Ramírez Morros A, Rodriguez Codina J, Amado Simon R, Grifols JR, Blanco J, Blanco I, Ara J, Bassat Q, Clotet B, Baro B, Troxel A, Zwaginga JJ, Mitjà O, Rijnders B, CoV Early study G, COnV ert study G. Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients. Nat. Commun. 2022;13(1):2583-2583. doi:10.1038/s41467-022-29911-3.
  • Parameswaran J, Goicoechea L, Planas Serra L, Pastor A, Ruiz M, Calingasan NY, Guilera C, Aso E, Boada J, Pamplona R, Portero Otín M, de la Torre R, Ferrer I, Casasnovas C, Pujol A, Fourcade S. Activating cannabinoid receptor 2 preserves axonal health through GSK-3ß/NRF2 axis in adrenoleukodystrophy. Acta Neuropathol. 2022;144(2):241-258. doi:10.1007/s00401-022-02451-2.
  • Solis O, Beccari AR, Iaconis D, Talarico C, Ruiz Bedoya CA, Nwachukwu JC, Cimini A, Castelli V, Bertini R, Montopoli M, Cocetta V, Borocci S, Prandi IG, Flavahan K, Bahr M, Napiorkowski A, Chillemi G, Ooka M, Yang XP, Zhang SL, Xia MH, Zheng W, Bonaventura J, Pomper MG, Hooper JE, Morales M, Rosenberg AZ, Nettles KW, Jain SK, Allegretti M, Michaelides M. The SARS-CoV-2 spike protein binds and modulates estrogen receptors. Sci. Adv. 2022;8(48):doi:10.1126/sciadv.add4150.
  • Bonaventura J, Gomez JL, Carlton ML, Lam S, Sanchez Soto M, Morris PJ, Moaddel R, Kang HJ, Zanos P, Gould TD, Thomas CJ, Sibley DR, Zarate CA, Michaelides M. Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search. Mol. Psychiatr. 2022;doi:10.1038/s41380-022-01673-w.

Research highlights

PROJECTS

4 Ongoing competitive projects

1 Ongoing clinical trial

NETWORKS

CannaLatan

Selected projects

  • 21INT002. Ecto-GPR37: a potential biomarker for Parkinson’s disease. (MJFF-001051). FUNDACIO IDIBELL; KAROLINSKA INSTITUTET; MICHAEL J FOX FOUNDATION. 2021-2023. IP: CIRUELA ALFEREZ, FRANCISCO.
  • 20FIS051. Plataforma de Unidades de Investigación Clínica y Ensayos Clínicos. (PT17/0017/0001). FUNDACIO IDIBELL; FUNDACIÓN INVESTIGACIÓN BIOMÉDICA H; ISCIII. 2020-2021. IP:HEREU BOHER,PILAR.
  • 21DPS003. Subvencions per a la formació de científics i tecnòlegs: modalitat personal investigador en formació (PIF-Salut). (SLT017/20/000114). DIR.GEN.SALUT PUBLICA, DEP.SALUT GE. 2021-2024. IP: CIRUELA ALFEREZ, FRANCISCO.
  • 20CEE009. Penumbral Rescue by Normobaric O=O Administration in Patients with Ischemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial. (733379). ECRIN – EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK. 2020-2022. IP:HEREU BOHER,PILAR.
  • 18FIS003. Plataforma de Unidades de Investigación Clínica y Ensayos Clínicos. (PT17/0017/0010). ISCIII. 2018-2021. IP:HEREU BOHER,PILAR.